Wernicke’s Encephalopathy

  • Maryam R. Kashi
  • George I. Henderson
  • Steven Schenker


Wernicke’s encephalopathy (WE) is a potentially reversible metabolic brain dysfunction resulting from thiamine deficiency. It is generally characterized by ataxia, ophthalmoplegia and global confusion. Described in Berlin in 1881 by Carl Wernicke, it was initially known as polioencephalitis hemorrhagica superioris and considered a fatal syndrome. The first reported cases were three patients, two with alcoholism and one with persistent vomiting after the ingestion of sulfuric acid in a suicide attempt. The common feature shared by these cases upon post-mortem exam consisted of punctate hemorrhages in the grey matter of the walls of the third and fourth ventricles and mammillary bodies (Cirignotta et al., 2000; Truswell, 2000). In 1935, Strauss discovered that the cause of Wernicke’s findings was vitamin B1 (thiamine) deficiency (Chiossi et al., 2006). Bonhoeffer posited that Wernicke’s encephalopathy and the psychosis described by Korsakoff actually represented two phases of the same pathological process (Cirignotta et al., 2000). The observation that Wernicke’s encephalopathy and Korsakoff’s psychosis have identical neuropathology supported this belief (Charness, 1999). Thus Wernicke’s encephalopathy (WE) and Korsakoff’s psychosis (KP) are often used interchangeably as the Wernicke-Korsakoff Syndrome (WKS).


Vasogenic Edema Apparent Diffusion Coefficient Mapping Thiamine Deficiency Alcoholic Patient Hyperemesis Gravidarum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank Amy L. Wyatt, R.D., L.D., affiliated with the University Hospital System in San Antonio, TX, for information provided on the content of thiamine in foods, as listed in Table 14.6. We gratefully acknowledge the excellent reviews by Drs. Roger Butterworth and colleagues (Hazell, 1998; Desjardins and Butterworth, 2005) and W.J. McEntee (1997), which served as valuable source material for this review.


  1. Aikawa, H., Watanabe, I.S., Furuse, T., Iwasaki, Y., Satoyoshi, E., Sumi, T., and Moroji, T. (1984). Low energy level in thiamine deficient encephalopathy. J. Neuropathol. Exp. Neurol. 43:276–287.PubMedCrossRefGoogle Scholar
  2. Ambrose, M.L., Bowden, S.C., and Whelan, G. (2001). Thiamin treatment and working memory function of alcohol-dependent people: preliminary findings. Alcohol. Clin. Exp. Res. 25:112–116.PubMedCrossRefGoogle Scholar
  3. Antunez, E., Estruch, R., Cardenal, C., Nicholas, J.M., Fernandez-Sola, J., and Urbano-Marquez, A. (1998). Usefulness of CT and MR Imaging in the diagnosis of acute Wernicke’s Encephalopathy. Am. J. Roentgenol. 171:1131–1137.Google Scholar
  4. Attard, O., Dietemann, J.L., Diemunsch, P., Pottecher, T., Meyer, A., and Calon, B.L. (2006). Wernicke encephalopathy: a complication of parenteral nutrition diagnosed by magnetic resonance imaging. Anesthesiology 105:847–848.PubMedCrossRefGoogle Scholar
  5. Bishai, D.M. and Bozzetti, L.P. (1986). Current progress toward the prevention of the Wernicke-Korsakoff syndrome. Alcohol Alcohol. 21:315–323.PubMedGoogle Scholar
  6. Blansjaar, B.A., Zwang, R., and Blijenberg, B.G. (1991). No transketolase abnormalities in Wernicke-Korsakoff patients. J. Neurol. Sci. 106:88–90.PubMedCrossRefGoogle Scholar
  7. Blass, J.P. and Gibson, G.E. (1977). Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. N. Engl. J. Med. 297:1367–1370.PubMedCrossRefGoogle Scholar
  8. Botez, M.I., Botez, T., Ross-Chouinard, A., and Lalonde, R. (1993). Thiamine and folate treatment of chronic epileptic patients: a controlled study with the Wechsler IQ scale. Epilepsy Res. 16:157–163.PubMedCrossRefGoogle Scholar
  9. Brady, J.A., Rock, C.L., and Horneffer, M.R. (1995). Thiamin status, diruretic medications, and the management of congestive heart failure. J. Am. Diet. Assoc. 95:541–544.PubMedCrossRefGoogle Scholar
  10. Breen, K.J., Buttigieg, R., Iossifidis, S., Lourensz, C., and Wood, B. (1985). Jejunal uptake of thiamin hydrocholoride in man: influence of alcoholism and alcohol. Am. J. Clin. Nutr. 42:121–126.PubMedGoogle Scholar
  11. Butterworth, R.F., Kril, J.J., and Harper, C.G. (1993). Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. Alcohol. Clin. Exp. Res. 17:1084–1088.PubMedCrossRefGoogle Scholar
  12. Caine, D., Halliday, G.M., Kril, J.J., and Harper, C.G. (1997). Operational criteria for the classification of chronic alcoholics identification of Wernicke’s encephalopathy. J. Neurol. Neurosurg. Psychiatr. 62:51–60.PubMedCrossRefGoogle Scholar
  13. Celik, Y. and Kaya, M. (2004). Brian SPECT findings in Wernicke’s encephalopathy. Neurol. Sci. 25:23–26.PubMedCrossRefGoogle Scholar
  14. Charness, M.E. (1999). Intracranial voyeurism: revealing the mammillary bodies in alcoholism. Alcohol. Clin. Exp. Res. 23:1941–1944.PubMedCrossRefGoogle Scholar
  15. Charness, M.E. (2006). Overview of the chronic neurologic complications of alcohol. www.uptodate.com, version 14.3; August 2006.
  16. Chiossi, G., Neri, I., Cavazzuti, M., Basso, G., and Facchinetti, F. (2006). Hyperemesis gravidarum complicated by Wernicke encephalopathy: background, case report, and review of the literature. Obstet. Gynecol. Surv. 61:255–268.PubMedCrossRefGoogle Scholar
  17. Chung, T.I., Kim, J.S., Park, S.K., Kim, B.S., Ahn, K.J., and Yang, D.W. (2003). Diffusion weighted MR imaging of acute Wernicke’s encephalopathy. Eur. J. Radiol. 45:256–258.PubMedCrossRefGoogle Scholar
  18. Cirignotta, F., Manconi, M., Mondini, S., Buzzi, G., and Ambrosetto, P. (2000). Wernicke-Korsakoff encephalopathy and polyneuropathy after gastroplasty for morbid obesity. Arch. Neurol. 57:1356–1359.PubMedCrossRefGoogle Scholar
  19. D’Aprile, P., Tarantino, A., Santoro, N., and Carella, A. (2000). Wernicke’s encephalopathy induced by total parenteral nutrition in patient with acute leukaemia: unusual involvement of caudate nuclei and cerebral cortex on MRI. Neuroradiology. 42:781–783.PubMedCrossRefGoogle Scholar
  20. Day, E., Bentham, P., Callaghan, R., Kuruvilla, T., and George, S. (2004). Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse. Cochrane Database Systematic Review, Issue 1, Art. No. CD004033.Google Scholar
  21. DeBari, V.A., Frank, O., Baker, H., and Needle, M.A. (1984). Water soluble vitamins in granulocytes, erythrocytes, and plasma obtained from chronic hemodialysis patients. Am. J. Clin. Nutr. 39:410–415.PubMedGoogle Scholar
  22. Desjardins, P. and Butterworth, R.F. (2005). Role of mitochondrial dysfunction and oxidative stress in the pathogenesis of selective neuronal loss in Wernicke’s encephalopathy. Mol. Neurobiol. 31:17–25.PubMedCrossRefGoogle Scholar
  23. Doherty, M.J., Watson, N.F., Uchino, K., Hallam, D.K., and Cramer, S.C. (2002). Diffusion abnormalities in patients with Wernicke encephalopathy. Neurology 58:655–657.PubMedCrossRefGoogle Scholar
  24. Dudeja, P.K., Tyagi, S., Gill, R., and Said, H.M. (2003). Evidence of a carrier-mediated mechanism for thiamine transport to human jejunal basolateral membrane vesicles. Dig. Dis. Sci. 48:109–115.PubMedCrossRefGoogle Scholar
  25. Dudeja, P.K., Tyagi, S., Kavilaveettil, R.J., Gill, R., and Said, H.M. (2001). Mechanism of thiamine uptake by human jejunal brush-border membrane vesicles. Am. J. Physiol. Cell Physiol. 281:C786–C792.PubMedGoogle Scholar
  26. Foster, D., Falah, M., Kadom, N., and Mandler, R. (2005). Wernicke encephalopathy after bariatric surgery: losing more than just weight. Neurology 65:1987.PubMedCrossRefGoogle Scholar
  27. Giglioli, L., Salani, B., and Mannucci, M. (2004). Case Report: Mental confusion, diplopia, and inability to stand in an 82 year-old-man. (Ltr. to Editor). J. Am. Geriatr. Soc. 52:1218.CrossRefGoogle Scholar
  28. Gui, Q.P., Zhao, W.Q., and Wang, L.N. (2006). Wernicek’s encephalopathy in nonalcoholic patients: clinical and pathologic features of three cases and literature reviewed. Neuropathology 26:231–235.PubMedCrossRefGoogle Scholar
  29. Halavaara, J., Brander, A., Lyytinen, J., Setälä, K., and Kallela, M. (2003). Neuroradiology. 45:519–523.PubMedCrossRefGoogle Scholar
  30. Harper, C. (1983). The incidence of Wernicke’s encephalopathy in Australia — a neuropathological study of 131 cases. J. Neurol. Neurosurg. Psychiatr. 46:593–598.PubMedCrossRefGoogle Scholar
  31. Harper, C.G., Giles, M., and Finlay-Jones, R. (1986). Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J. Neurol. Neurosurg. Psychiatr. 49:341–345.PubMedCrossRefGoogle Scholar
  32. Harrison, R.A., Vu, T., and Hunter, A.J. (2006). Wernicke’s encephalopathy in a patient with schizophrenia. J. Gen. Intern. Med. 21:C8–C11.PubMedCrossRefGoogle Scholar
  33. Hazell, A.S., Todd, K.G., and Butterworth, R.F. (1998). Mechanisms of neuronal cell death in Wernicke’s encephalopathy. Metab. Brain Dis. 13:97–122.PubMedCrossRefGoogle Scholar
  34. Heier, M.S. and Dornish, J.M. (1989). Effect of the fluoropyrimidines 5-fluorourcil and Doxifluridine on cellular uptake of thiamin. Anticancer Res. 9:1073–1077.PubMedGoogle Scholar
  35. Heinze, T. and Weber, W. (1990). Determination of thiamine (vitamin B1) in maternal blood during normal pregnancies and pregnancies with intrauterine growth retardation. Zeit. Ernahrungswissensch. 29:39–46.CrossRefGoogle Scholar
  36. Hochhalter, A.K. and Joseph, B. (2001). Differential outcomes training facilitates memory in people with Korsakoff and Prader-Willi syndromes. Integr. Physiol. Behav. Sci. 36:196–204.PubMedCrossRefGoogle Scholar
  37. Holowach, J., Kaufmann, F., Ikossi, M.G., Thomas, C. and McDougal, D.B. (1968). The effects of a thiamine antagonist, pyrithiamine, on levels of selected metabolic intermediates and activities of thiamine dependent enzymes in brain and liver. J. Neurochem. 15:621–631.PubMedCrossRefGoogle Scholar
  38. Holzbach, E. (1996). Thiamine absorption in alcoholic delirium patients. J. Stud. Alcohol 57:581–584.PubMedGoogle Scholar
  39. Homewood, J., and Bond, N.W. (1999). Thiamin deficiency and Korsakoff’s syndrome: failure to find memory impairments following nonalcoholic Wernicke’s encephalopathy. Alcohol 19:75–84.PubMedCrossRefGoogle Scholar
  40. Hoyumpa, A.M., Jr. (1980). Mechanisms of thiamin deficiency in chronic alcoholism. Am. J. Clin. Nutr. 33:2750–2761.PubMedGoogle Scholar
  41. Hung, S.C., Hung, S.H., Tarng, D.C., Yang, W.C., Chen, T.W., and Huang, T.P. (2001). Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am. J. Kidney Dis. 38:941–947.PubMedCrossRefGoogle Scholar
  42. Kaufmann, A., Uhlhaas, S., Friedl, W., and Propping, P. (1987). Human erythrocyte transketolase: no evidence for variants. Clin. Chim. Acta. 162:215–219.PubMedCrossRefGoogle Scholar
  43. Kesler, A., Stolovitch, C., Hoffmann, C., Avni, I., and Morad, Y. (2005). Acute ophthalmoplegia and nystagmus in infants fed a thiamine-deficient formula: an epidemic of Wernicke encephalopathy. J. Neuroophthalmol. 25:169–172.PubMedCrossRefGoogle Scholar
  44. Koguchi, K., Nakatsuji, Y., Abe, K., and Sakoda, S. (2004). Wernicke’s encephalopathy after glucose infusion. Neurology 62:512.PubMedCrossRefGoogle Scholar
  45. Koontz, D.W., Fernandes-Filho, J.A.F., Sagar, S.M., and Rucker, J.C. (2004). Wernicke encephalopathy. Neurology 63:394.PubMedCrossRefGoogle Scholar
  46. Kumar, D., Nartsupha, C., and West, B.C. (2000). Unilateral internuclear ophthalmoplegia and recovery with thiamine in Wernicke syndrome. Am. J. Med. Sci. 320:278–280.PubMedCrossRefGoogle Scholar
  47. Kumar, D., Nartsupha, C., and West, B.C. (2008). Unilateral internuclear ophthalmoplegia and recovery with thiamine in Wernicke syndrome. Alcohol Clin Exp Res 32:1091–1095.CrossRefGoogle Scholar
  48. Lacasse, L. and Lun, C. (2004). Wernicke encephalopathy in a patient with T-Cell leukemia and severe malnutrition. Can. J. Neurol. Sci. 31:97–98.PubMedGoogle Scholar
  49. Liu, Y.T., Fuh, J.L., Lirng, J.F., Li, A.F.Y., and Ho, D.M.T. (2006). Correlation of magnetic resonance images with neuropathology in acute Wernicke’s encephalopathy. Clin. Neurol. Neurosurg. 108:682–687.PubMedCrossRefGoogle Scholar
  50. Loh, Y., Watson, W.D., Verma, A., Chang, S.T., Stocker, D.J., and Labutta, R.J. (2004). Acute Wernicke’s encephalopathy following bariatric surgery: clinical course and MRI correlation. Obesity Surg. 14:129–132.CrossRefGoogle Scholar
  51. Lonsdale, D. (2006). A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. Evid. Based Complement. Alternat. Med. 3:49–59.Google Scholar
  52. Martin, P.R., McCool, B.A., and Singleton, C.K. (1995). Molecular genetics of transketolase in the pathogenesis of the Wernicke-Korsakoff syndrome. Metab. Brain Dis. 10:45–55.PubMedCrossRefGoogle Scholar
  53. Mascalchi, M., Simonelli, P., Tessa, C., Giangaspero, F., Petruzzi, P., Bosincu, L., Conti, M., Sechi, G., and Salvi, F. (1999). Do acute lesions of Wernicke’s encephalopathy show contrast enhancement? Report of three cases and review of the literature. Neuroradiology 41:249–254.PubMedCrossRefGoogle Scholar
  54. Masud, T. (2002). Trace elements and vitamins in renal disease. In (W.E. Mitch, and Klahr, S. eds.), Handbook of Nutrition and the Kidney, 4th edn, Lippincott, Philadelphia, pp. 233–252.Google Scholar
  55. McCandless, D.W. (1982). Energy metabolism in the lateral vestibular nucleus in pryithiamin-induced thiamin deficiency. Ann. N.Y. Acad. Sci. 378:355–364.PubMedCrossRefGoogle Scholar
  56. McCandless, D.W., Curley, A.D. and Cassidy, C.E. (1976). Thiamine deficiency and the pentose phosphate cycle in rats: intracerebral mechanisms. J. Nutr. 106:1144–1151.PubMedGoogle Scholar
  57. McCandless, D.W. and Schenker, S. (1968). Encephalopathy of thiamine deficiency: studies of intracerebral mechanisms. J. Clin. Invest. 47:2268–2280.PubMedCrossRefGoogle Scholar
  58. McCandless, D.W. and Schwartzenburg, F.C., Jr. (1981). The effect of thiamine deficiency on energy metabolism in cells of the lateral vestibular nucleus. Res. Comm. Psychol. Psychiat. Behav. 6:183–190.Google Scholar
  59. McEntee, W.J. (1997). Wernicke’s encephalopathy: an excitotoxicity hypothesis. Metab. Brain Dis. 12:183–192.PubMedGoogle Scholar
  60. Merkin-Zaborsky, H., Ifergane, G., Frisher, S., Valdman, S., Herishanu, Y.L., and Wirguin, I. (2001). Thiamine-responsive acute neurological disorders in nonalcoholic patients. Eur. Neurol. 45:34–37.PubMedCrossRefGoogle Scholar
  61. Morcos, Z., Kerns, S.C., and Shapiro, B.E. (2004). Wernicke encephalopathy. Arch. Neurol. 61:775–776.PubMedCrossRefGoogle Scholar
  62. Nixon, P.F., Kaczmarek, M.J., Tate, J., Kerr, R.A., and Price, J. (1984). An erythrocyte transketolase isoenzyme pattern associated with the Wernicke-Korsakoff Syndrome. Eur. J. Clin. Invest. 14:278–281.PubMedCrossRefGoogle Scholar
  63. Ogershok, P.R., Rahman, A., Nestor, S., and Brick, J. (2002). Wernicke encephalopathy in nonalcoholic patients. Am. J. Med. Sci. 323:107–111.PubMedCrossRefGoogle Scholar
  64. Patrini, C., Perucca, E., Reggiani, C., and Rindi, G. (1993). Effects of phenytoin on the in vivo kinetics of thiamine and its phosphoesters in rat nervous tissues. Brain Res. 628:179–186.PubMedCrossRefGoogle Scholar
  65. Pazirandeh, S., Lo, C.W., and Burns, D.L. (2006). Overview of water-soluble vitamins. www.uptodate.com, version 14.3.
  66. Peters, R.A. (1969). The biochemical lesion and its historical development. Br. Med. Bull. 25:223–226.PubMedGoogle Scholar
  67. Piccoli, G.B., Burdese, M., Mezza, E., Soragna, G., Tattoli, F., Consiglio, V., Maddalena, E., Bergui, M., Scarzella, G., and Segoloni, G.P. (2006). The suddenly speechless florist on chronic dialysis: the unexpected threats of a flower shop? Nephrol. Dial. Transplant. 21:223–225.CrossRefGoogle Scholar
  68. Price, J. and Kerr, R. (1985). Some observations on the Wernicke Korsakoff syndrome in Australia. Br. J. Addict. 80:69–76.PubMedCrossRefGoogle Scholar
  69. Rathinam, M.L., Watts, L.T., Start, A.A., Mihimainathan, L., Stewart, J., Schenker, S., and Henderson, G.I. (2006). Astrocyte control of fetal cortical neuron glutathione homeostasis: up-regulation by ethanol. J. Neurochem. 96:1289–1300.PubMedCrossRefGoogle Scholar
  70. Reidling, J.C., Subramanian, V.S., Dudeja, P.K., and Siad, H.M. (2002). Expression and promoter analysis of SLC19A2 in the human intestine. Biochim. Biophys. Acta 1561:180–187.PubMedCrossRefGoogle Scholar
  71. Reuler, J.B., Girard, D.E., and Cooney, T.G. (1985). Current Concepts: Wernicke’s encephalopathy. N. Eng. J. Med. 312:1035–1039.CrossRefGoogle Scholar
  72. Rindi, G. and Ventura, U. (1972). Thiamine intestinal transport. Physiol. Rev. 52:821–827.PubMedGoogle Scholar
  73. Seligmann, H., Halkin, H., Rauchfleisch, S., Kaufmann, N., Motro, M., Vered, Z., and Ezra, D. (1991). Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am. J. Med. 91:151–155.PubMedCrossRefGoogle Scholar
  74. Shogry, M.E. and Curnes, J.T. (1994). Mammillary body enhancement on MR as the on1ly sign of acute Wernicke encephalopathy. Am. J. Neuroradiol. 15:172–174.PubMedGoogle Scholar
  75. Sivolap, Y.P. (2005). The current state of S.S. Korsakov’s concept of alcoholic polyneuritic psychosis. Neurosci. Behav. Physiol. 35:977–982.PubMedCrossRefGoogle Scholar
  76. Squirrell, D. (2004). Wernicke encephalopathy. Arch. Ophthalmol. 122:418–419.PubMedCrossRefGoogle Scholar
  77. The Food Processor SQL. (2006). www.esha.com/foodprocessorsql; version 9.9.0
  78. Thomson, A., Baker, H., and Leevy, C.M. (1968). Thiamine absorption in alcoholism. Am. J. Clin. Nutr. 21:537.Google Scholar
  79. Tomasulo, P.A., Kater, R.M.H., and Iber, F.L. (1968). Impairment of thiamine absorption in alcoholism. Am. J. Clin. Nutr. 21:1340–1344.Google Scholar
  80. Truswell, A.S. (2000). Australian experience with the Wernicke-Korsakoff syndrome. Addiction 95:829–832.PubMedCrossRefGoogle Scholar
  81. Victor, M., Adams, R.D., and Collins, G.H., eds. (1989). Course in the illness. In: The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition, Davis, Philadelphia, pp. 31–38.Google Scholar
  82. Vorhees, C.V., Schmidt, D.E., Barrett, R.J., and Schenker, S. (1977). Effect of thiamin deficiency on acetylcholine levels and utilization in vivo in rat brain. J. Nutr. 107:1902–1908.PubMedGoogle Scholar
  83. Weidauer, S., Rosler, A., Zanella, F.E., and Lanfermann, H. (2004). Diffusion-weighted imaging in Wernicke encephalopathy associated with stomach cancer: case report and review of the literature. Eur. Neurol. 51:55–57.PubMedCrossRefGoogle Scholar
  84. White, M.L., Zhang, Y., Andrew, L.G., and Hadley, W.L. (2005). MR imaging with diffusion-weighted imaging in acute and chronic Wernicke encephalopathy. Am. J. Neuroradiol. 26:2306–2310.PubMedGoogle Scholar
  85. Wood, B., Currie, J., and Breen, K. (1984). Wernicke’s encephalopathy in a metropolitan hospital. A prospective study of incidence, characteristics and outcome. Med. J. Aust. 144:12–16.Google Scholar
  86. Worden, R.W. and Allen, H.M. (2006). Wernicke’s encephalopathy after gastric bypass that masqueraded as acute psychosis: a case report. Curr. Surg. 63:114–116.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Maryam R. Kashi
    • 1
  • George I. Henderson
    • 1
  • Steven Schenker
    • 1
  1. 1.Department of Medicine, Division of Gastroenterology and NutritionUniversity of Texas Health Science CenterSan AntonioUSA

Personalised recommendations